Larson Financial Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12K | Buy |
364
+297
| +443% | +$9.81K | ﹤0.01% | 1708 |
|
2025
Q1 | $2.69K | Buy |
67
+64
| +2,133% | +$2.57K | ﹤0.01% | 2058 |
|
2024
Q4 | $141 | Buy |
+3
| New | +$141 | ﹤0.01% | 2528 |
|
2023
Q4 | – | Sell |
-300
| Closed | -$8.84K | – | 1820 |
|
2023
Q3 | $8.84K | Buy |
300
+154
| +105% | +$4.54K | ﹤0.01% | 1033 |
|
2023
Q2 | $4.76K | Hold |
146
| – | – | ﹤0.01% | 1115 |
|
2023
Q1 | $5.14K | Buy |
+146
| New | +$5.14K | ﹤0.01% | 1078 |
|